Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
Journal Article
Kountouras, J., Polyzos S. A., Gavalas E., Boziki M., Katsinelos P., Zeglinas C., et al. (2016).  A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology.. J Gastrointestin Liver Dis. 25(3), 405-6.
Kountouras, J., Papaefthymiou A., Polyzos S. A., & Doulberis M. (2022).  Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology.. J Gastrointest Cancer.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Zavos C., Vagdatli E., et al. (2020).  Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap.. J Clin Gastroenterol. 54(2), 200-201.
Kountouras, J., Polyzos S. A., Katsinelos P., Anastasiadis S., Tzivras D., Doulberis M., et al. (2018).  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.. Dig Dis Sci. 63(4), 1087-1088.
Boziki, M., Polyzos S. A., Deretzi G., Kazakos E., Katsinelos P., Doulberis M., et al. (2018).  A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration.. Neurochem Int. 113, 137-151.
Boziki, M., Grigoriadis N., Doulberis M., Papaefthymiou A., Polyzos S. A., & Kountouras J. (2020).  Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis.. Dig Liver Dis. 52(1), 121-123.
Kountouras, J., Zavos C., Polyzos S. A., & Deretzi G. (2016).  Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration.. Ann Gastroenterol. 29(1), 99.
Kountouras, J., Doulberis M., Polyzos S. A., Tzitiridou M., Chatzopoulos D., Gialamprinou D., et al. (2022).  A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery.. Gastrointest Endosc. 96(6), 1088-1089.
Kountouras, J., Polyzos S. A., Doulberis M., Zeglinas C., Artemaki F., Vardaka E., et al. (2018).  Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.. Metabolism. 87, 18-24.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kyrailidi F., & Doulberis M. (2022).  Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes.. Am J Hypertens.
Boziki, M., Polyzos S. A., Papaefthymiou A., Doulberis M., Bakirtzis C., Sintila S-A., et al. (2021).  Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders.. Metabolism. 154736.
Kountouras, J., Papaefthymiou A., Polyzos S. A., & Doulberis M. (2021).  A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension.. Liver Int.
Kountouras, J., Kazakos E., Polyzos S. A., Papaefthymiou A., Zavos C., Tzitiridou-Chatzopoulou M., et al. (2023).  Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease.. Clin Immunol. 256, 109776.
Kountouras, J., Zavos C., Deretzi G., Gavalas E., Chatzopoulos D., Katsinelos P., et al. (2012).  Potential implications of Helicobacter pylori-related neutrophil-activating protein.. World J Gastroenterol. 18(5), 489-90.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Kountouras C., Vardaka E., et al. (2016).  Potential molecular aspects of Helicobacter pylori-related hyperplastic polyp development and progression.. Eur J Gastroenterol Hepatol. 28(7), 851-2.
Kapetanakis, N., Kountouras J., Zavos C., Anastasiadou K., Tsarouchas G., Michael S., et al. (2013).  Potential oncogenic properties of mobilized stem cells in a subpopulation of inflammatory bowel disease patients infected with Helicobacter pylori.. Inflamm Bowel Dis. 19(2), E27-9.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  The potentially dual-faceted nature of fetuin-A in Helicobacter pylori infection and insulin resistance.. Clinics (Sao Paulo). 66(5), 911-2.
Anagnostis, P., Adamidou F., Polyzos S. A., Katergari S., Karathanasi E., Zouli C., et al. (2013).  Predictors of long-term remission in patients with Graves' disease: a single center experience.. Endocrine. 44(2), 448-53.
Tsirona, S., Katsaros F., Bargiota A., Polyzos S. A., Arapoglou G., & Koukoulis G. N. (2016).  Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population.. Hormones (Athens). 15(1), 88-98.
Polyzos, S. A., Anastasilakis A. D., Iakovou I. P., & Partsalidou V. (2010).  Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man.. Arq Bras Endocrinol Metabol. 54(6), 578-82.
Polyzos, S. A., Anastasilakis A. D., Litsas I., Efstathiadou Z., Kita M., Arsos G., et al. (2010).  Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.. J Bone Miner Metab. 28(6), 706-12.
Anastasilakis, A. D., Trovas G., Balanika A., Polyzos S. A., Makras P., & Tournis S. (2020).  Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be Enough.. J Clin Densitom.
Polyzos, S. A. (2011).  Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.. Clin Rheumatol. 30(1), 149-50.
Kountouras, J., Deretzi G., Gavalas E., Zavos C., Polyzos S. A., Kazakos E., et al. (2014).  A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders.. Med Hypotheses. 82(3), 368-73.
Anastasilakis, A. D., Toulis K. A., Polyzos S. A., & Terpos E. (2009).  RANKL inhibition for the management of patients with benign metabolic bone disorders.. Expert Opin Investig Drugs. 18(8), 1085-102.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.